Abstract
Tumors possess many features that differentiate them from normal tissues which can potentially be targeted for therapy. One such difference is the presence of an inefficient vascular network, which is often unable to meet the tumor’s needs. The interaction of this faulty vascular system with the cells within the tumor leads to the development of a unique tumor microenvironment not found in normal tissues. This particular environment has a number of distinct features such as low oxygen concentrations, high interstitial fluid pressures and low pH. Previous studies have found that the presence of these microenvironmental conditions potentiates the development of certain adaptive responses by the tumor. These adaptive responses can have a number of adverse consequences, including increased resistance to chemo and radiotherapy. Nevertheless, since these microenvironmental characteristics are found in most solid tumor types, they have a profound effect on the tumor’s behavior and represent attractive therapeutic targets.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Alarcon R, Koumenis C, Geyer RK et al (1999) Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation. Cancer Res 59:6046–6051
Alarcon RM, Denko NC, Giaccia AJ (2001) Genetic determinants that influence hypoxia-induced apoptosis. Novartis Found Symp 240:115–128
Bartek J, Lukas J (2003) Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3:421–429
Bencokova Z, Kaufmann MR, Pires IM et al (2009) ATM activation and signaling under hypoxic conditions. Mol Cell Biol 29:526–537
Bertrand P, Lambert S, Joubert C et al (2003) Overexpression of mammalian Rad51 does not stimulate tumorigenesis while a dominant-negative Rad51 affects centrosome fragmentation, ploidy and stimulates tumorigenesis, in p53-defective CHO cells. Oncogene 22:7587–7592
Bindra RS, Glazer PM (2007) Co-repression of mismatch repair gene expression by hypoxia in cancer cells: Role of the Myc/Max network. Cancer Lett 252:93–103
Bindra RS, Schaffer PJ, Meng A et al (2004) Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells. Mol Cell Biol 24:8504–8518
Bindra RS, Gibson SL, Meng A et al (2005) Hypoxia-induced down-regulation of BRCA1 expression by E2Fs. Cancer Res 65:11597–11604
Bindra RS, Crosby ME, Glazer PM (2007) Regulation of DNA repair in hypoxic cancer cells. Cancer Metastasis Rev 26:249–260
Bristow RG, Hill RP (2008) Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer 8:180–192
Brizel DM, Scully SP, Harrelson JM et al (1996) Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56:941–943
Brown JM (1979) Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol 52:650–656
Brown JM (2002) Tumor microenvironment and the response to anticancer therapy. Cancer Biol Ther 1:453–458
Brown EJ, Baltimore D (2003) Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance. Genes Dev 17:615–628
Brown JM, Giaccia AJ (1998) The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 58:1408–1416
Brown JM, Wilson WR (2004) Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 4:437–447
Bryant HE, Schultz N, Thomas HD et al (2005) Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434:913–917
Cairns R, Papandreou I, Denko N (2006) Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment. Mol Cancer Res 4:61–70
Cardenas-Navia LI, Mace D, Richardson RA et al (2008) The pervasive presence of fluctuating oxygenation in tumors. Cancer Res 68:5812–5819
Carney JP, Maser RS, Olivares H et al (1998) The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell 93:477–486
Chan N, Koritzinsky M, Zhao H et al (2008) Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance. Cancer Res 68:605–614
Choudhury A, Cuddihy A, Bristow RG (2006) Radiation and new molecular agents part I: targeting ATM-ATR checkpoints, DNA repair, and the proteasome. Semin Radiat Oncol 16:51–58
Cimprich KA, Cortez D (2008) ATR: an essential regulator of genome integrity. Nat Rev Mol Cell Biol 9:616–627
Coleman ML, Ratcliffe PJ (2009) Angiogenesis: escape from hypoxia. Nat Med 15:491–493
Collis SJ, DeWeese TL, Jeggo PA et al (2005) The life and death of DNA-PK. Oncogene 24:949–961
Costanzo V, Robertson K, Bibikova M et al (2001) Mre11 protein complex prevents double-strand break accumulation during chromosomal DNA replication. Mol Cell 8:137–147
Crosby ME, Devlin CM, Glazer PM et al (2009a) Emerging roles of microRNAs in the molecular responses to hypoxia. Curr Pharm Des 15:3861–3866
Crosby ME, Kulshreshtha R, Ivan M et al (2009b) MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res 69:1221–1229
D’Amours D, Jackson SP (2002) The Mre11 complex: at the crossroads of DNA repair and checkpoint signalling. Nat Rev Mol Cell Biol 3:317–327
Denko N, Wernke-Dollries K, Johnson AB et al (2003) Hypoxia actively represses transcription by inducing negative cofactor 2 (Dr1/DrAP1) and blocking preinitiation complex assembly. J Biol Chem 278:5744–5749
Economopoulou M, Langer HF, Celeste A et al (2009) Histone H2AX is integral to hypoxia-driven neovascularization. Nat Med 15:553–558
Farmer H, McCabe N, Lord CJ et al (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434:917–921
Freiberg RA, Hammond EM, Dorie MJ et al (2006) DNA damage during reoxygenation elicits a Chk2-dependent checkpoint response. Mol Cell Biol 26:1598–1609
Gardner LB, Li F, Yang X et al (2003) Anoxic fibroblasts activate a replication checkpoint that is bypassed by E1a. Mol Cell Biol 23:9032–9045
Gibson SL, Bindra RS, Glazer PM (2005) Hypoxia-induced phosphorylation of Chk2 in an ataxia telangiectasia mutated-dependent manner. Cancer Res 65:10734–10741
Goodarzi AA, Jonnalagadda JC, Douglas P et al (2004) Autophosphorylation of ataxia-telangiectasia mutated is regulated by protein phosphatase 2A. EMBO J 23:4451–4461
Graeber TG, Osmanian C, Jacks T et al (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379:88–91
Green SL, Freiberg RA, Giaccia AJ (2001) p21(Cip1) and p27(Kip1) regulate cell cycle reentry after hypoxic stress but are not necessary for hypoxia-induced arrest. Mol Cell Biol 21:1196–1206
Hammond EM, Denko NC, Dorie MJ et al (2002) Hypoxia links ATR and p53 through replication arrest. Mol Cell Biol 22:1834–1843
Hammond EM, Dorie MJ, Giaccia AJ (2003a) ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation. J Biol Chem 278:12207–12213
Hammond EM, Green SL, Giaccia AJ (2003b) Comparison of hypoxia-induced replication arrest with hydroxyurea and aphidicolin-induced arrest. Mutat Res 532:205–213
Hammond EM, Dorie MJ, Giaccia AJ (2004) Inhibition of ATR leads to increased sensitivity to hypoxia/reoxygenation. Cancer Res 64:6556–6562
Heffernan TP, Simpson DA, Frank AR et al (2002) An ATR- and Chk1-dependent S checkpoint inhibits replicon initiation following UVC-induced DNA damage. Mol Cell Biol 22:8552–8561
Helleday T, Lo J, van Gent DC et al (2007) DNA double-strand break repair: from mechanistic understanding to cancer treatment. DNA Repair (Amst) 6:923–935
Hockel M, Schlenger K, Aral B et al (1996) Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56:4509–4515
Huang LE, Bindra RS, Glazer PM et al (2007) Hypoxia-induced genetic instability – a calculated mechanism underlying tumor progression. J Mol Med 85:139–148
Huen MS, Grant R, Manke I et al (2007) RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly. Cell 131:901–914
Hunt CR, Pandita RK, Laszlo A et al (2007) Hyperthermia activates a subset of ataxia-telangiectasia mutated effectors independent of DNA strand breaks and heat shock protein 70 status. Cancer Res 67:3010–3017
Jaakkola P, Mole DR, Tian YM et al (2001) Targeting of HIF-alpha to the von Hippel–Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292:468–472
Jackson SP, Bartek J (2009) The DNA-damage response in human biology and disease. Nature 461:1071–1078
Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307:58–62
Jeong I, Patel AY, Zhang Z et al (2010) Role of ataxia telangiectasia mutated in insulin signalling of muscle-derived cell lines and mouse soleus. Acta Physiol (Oxf) 98:465–475
Kaelin WG, Jr. (2005) The concept of synthetic lethality in the context of anticancer therapy. Nat Rev Cancer 5:689–698
Kaelin WG, Jr., Ratcliffe PJ (2008) Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 30:393–402
Kim BM, Choi JY, Kim YJ et al (2007) Reoxygenation following hypoxia activates DNA-damage checkpoint signaling pathways that suppress cell-cycle progression in cultured human lymphocytes. FEBS Lett 581:3005–3012
Kolas NK, Chapman JR, Nakada S et al (2007) Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase. Science 318:1637–1640
Koritzinsky M, Magagnin MG, van den Beucken T et al (2006) Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control. EMBO J 25:1114–1125
Koshiji M, To KK, Hammer S, Kumamoto K, Harris AL, Modrich P, Huang LE (2005) HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression. Mol Cell 17:793–803
Koumenis C, Alarcon R, Hammond E et al (2001) Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol Cell Biol 21:1297–1310
Kovacs K, Toth A, Deres P et al (2004) Myocardial protection by selective poly(ADP-ribose) polymerase inhibitors. Exp Clin Cardiol 9:17–20
Lara PC, Lloret M, Clavo B et al (2008) Hypoxia downregulates Ku70/80 expression in cervical carcinoma tumors. Radiother Oncol 89:222–226
Lavin MF (2008) Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol 9:759–769
Lee JH, Paull TT (2004) Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science 304:93–96
Li CY, Little JB, Hu K et al (2001) Persistent genetic instability in cancer cells induced by non-DNA-damaging stress exposures. Cancer Res 61:428–432
Liu SK, Coackley C, Krause M et al (2008) A novel poly(ADP-ribose) polymerase inhibitor, ABT-888, radiosensitizes malignant human cell lines under hypoxia. Radiother Oncol 88:258–268
Loeb LA (2001) A mutator phenotype in cancer. Cancer Res 61:3230–3239
Loehberg CR, Thompson T, Kastan MB et al (2007) Ataxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis. Cancer Res 67:12026–12033
Mailand N, Bekker-Jensen S, Faustrup H et al (2007) RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins. Cell 131:887–900
Martin SA, Lord CJ, Ashworth A (2008) DNA repair deficiency as a therapeutic target in cancer. Curr Opin Genet Dev 18:80–86
Martin-Oliva D, Aguilar-Quesada R, O’Valle F et al (2006) Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis. Cancer Res 66:5744–5756
Maxwell PH, Wiesener MS, Chang GW et al (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271–275
Maya-Mendoza A, Petermann E, Gillespie DA et al (2007) Chk1 regulates the density of active replication origins during the vertebrate S phase. EMBO J 26:2719–2731
McCabe N, Turner NC, Lord CJ et al (2006) Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition. Cancer Res 66:8109–8115
Meng AX, Jalali F, Cuddihy A et al (2005) Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells. Radiother Oncol 76:168–176
Mihaylova VT, Bindra RS, Yuan J et al (2003) Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells. Mol Cell Biol 23:3265–3273
Minchinton AI, Tannock IF (2006) Drug penetration in solid tumours. Nat Rev Cancer 6:583–592
Minter-Dykhouse K, Ward I, Huen MS et al (2008) Distinct versus overlapping functions of MDC1 and 53BP1 in DNA damage response and tumorigenesis. J Cell Biol 181:727–735
Nordsmark M, Hoyer M, Keller J et al (1996a) The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas. Int J Radiat Oncol Biol Phys 35:701–708
Nordsmark M, Overgaard M, Overgaard J (1996b) Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 41:31–39
O’Neill P, Wardman P (2009) Radiation chemistry comes before radiation biology. Int J Radiat Biol 85:9–25
Pan Y, Oprysko PR, Asham AM et al (2004) p53 cannot be induced by hypoxia alone but responds to the hypoxic microenvironment. Oncogene 23:4975–4983
Pandita TK, Pandita S, Bhaumik SR (2009) Molecular parameters of hyperthermia for radiosensitization. Crit Rev Eukaryot Gene Expr 19:235–251
Pellegrini M, Celeste A, Difilippantonio S et al (2006) Autophosphorylation at serine 1987 is dispensable for murine Atm activation in vivo. Nature 443:222–225
Petermann E, Maya-Mendoza A, Zachos G et al (2006) Chk1 requirement for high global rates of replication fork progression during normal vertebrate S phase. Mol Cell Biol 26:3319–3326
Pires IM, Bencokova Z, Milani M et al (2010) Effects of acute versus chronic hypoxia on dna damage responses and genomic instability. Cancer Res 70:925–935
Poon E, Harris AL, Ashcroft M (2009) Targeting the hypoxia-inducible factor (HIF) pathway in cancer. Expert Rev Mol Med 11:e26
Powell SN, Kachnic LA (2003) Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation. Oncogene 22:5784–5791
Quiles-Perez R, Munoz-Gamez JA, Ruiz-Extremera A et al (2010) Inhibition of poly adenosine diphosphate-ribose polymerase decreases hepatocellular carcinoma growth by modulation of tumor-related gene expression. Hepatology 51:255–266
Rankin EB, Giaccia AJ, Hammond EM (2009) Bringing H2AX into the angiogenesis family. Cancer Cell 15:459–461
Reichard P, Ehrenberg A (1983) Ribonucleotide reductase – a radical enzyme. Science 221:514–519
Reynolds TY, Rockwell S, Glazer PM (1996) Genetic instability induced by the tumor microenvironment. Cancer Res 56:5754–5757
Richard DJ, Bolderson E, Cubeddu L et al (2008) Single-stranded DNA-binding protein hSSB1 is critical for genomic stability. Nature 453:677–681
Sandhu JK, Haqqani AS, Birnboim HC (2000) Effect of dietary vitamin E on spontaneous or nitric oxide donor-induced mutations in a mouse tumor model. J Natl Cancer Inst 92:1429–1433
Shannon AM, Bouchier-Hayes DJ, Condron CM et al (2003) Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. Cancer Treat Rev 29:297–307
Soengas MS, Alarcon RM, Yoshida H et al (1999) Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 284:156–159
Sprong D, Janssen HL, Vens C et al (2006) Resistance of hypoxic cells to ionizing radiation is influenced by homologous recombination status. Int J Radiat Oncol Biol Phys 64:562–572
Stark JM, Pierce AJ, Oh J et al (2004) Genetic steps of mammalian homologous repair with distinct mutagenic consequences. Mol Cell Biol 24:9305–9316
Stewart GS, Maser RS, Stankovic T et al (1999) The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 99:577–587
Stiff T, Walker SA, Cerosaletti K et al (2006) ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling. EMBO J 25:5775–5782
Sugimura K, Takebayashi S, Taguchi H et al (2008) PARP-1 ensures regulation of replication fork progression by homologous recombination on damaged DNA. J Cell Biol 183:1203–1212
Syljuasen RG, Sorensen CS, Hansen LT et al (2005) Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage. Mol Cell Biol 25:3553–3562
To KK, Sedelnikova OA, Samons M et al (2006) The phosphorylation status of PAS-B distinguishes HIF-1alpha from HIF-2alpha in NBS1 repression. EMBO J 25:4784–4794
Um JH, Kang CD, Bae JH et al (2004) Association of DNA-dependent protein kinase with hypoxia inducible factor-1 and its implication in resistance to anticancer drugs in hypoxic tumor cells. Exp Mol Med 36:233–242
Uziel T, Lerenthal Y, Moyal L et al (2003) Requirement of the MRN complex for ATM activation by DNA damage. EMBO J 22:5612–5621
Vaupel P, Harrison L (2004) Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. Oncologist 9 Suppl 5:4–9
Wang B, Elledge SJ (2007) Ubc13/Rnf8 ubiquitin ligases control foci formation of the Rap80/Abraxas/Brca1/Brcc36 complex in response to DNA damage. Proc Natl Acad Sci USA 104:20759–20763
Wardman P (2007) Chemical radiosensitizers for use in radiotherapy. Clin Oncol (R Coll Radiol) 19:397–417
Wardman P (2009) The importance of radiation chemistry to radiation and free radical biology (The 2008 Silvanus Thompson Memorial Lecture). Br J Radiol 82:89–104
Yuan J, Narayanan L, Rockwell S et al (2000) Diminished DNA repair and elevated mutagenesis in mammalian cells exposed to hypoxia and low pH. Cancer Res 60:4372–4376
Zou L, Elledge SJ (2003) Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300:1542–1548
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Hammond, E.M., Olcina, M., Giaccia, A.J. (2011). Hypoxia and Modulation of Cellular Radiation Response. In: DeWeese, T., Laiho, M. (eds) Molecular Determinants of Radiation Response. Current Cancer Research. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-8044-1_6
Download citation
DOI: https://doi.org/10.1007/978-1-4419-8044-1_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-8043-4
Online ISBN: 978-1-4419-8044-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)